Graf Akcie BDSI (Biodelivery Sciences International). Diskuze k akciím BDSI. Aktuální informace BDSI.

Základní informace o společnosti Biodelivery Sciences International (Akcie BDSI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 400.13M
Hodnota podniku (EV) N/A
Tržby 164.069M
EBITDA N/A
Zisk 33.88M
Růst v tržbách Q/Q 13.28 %
Růst v tržbách Y/Y 19.93 %
P/E (Cena vůči ziskům) 12.15
Forward P/E 0.10
EV/Sales 1.97
EV/EBITDA N/A
EV/EBIT 18.87
PEG 0.76
Price/Sales 2.44
P/FCF 10.03
Price/Book 3.70
Účetní hodnota na akcii 1.08
Hotovost na akcii 1.12
FCF vůči ceně 9.97 %
Počet zaměstnanců 176
Tržba na zaměstnance 932.210k
Profit margin 16.43 %
Operating margin 26.13 %
Gross margin 84.24 %
EBIT margin 26.12 %
EBITDA margin 8.61 %
EPS - Zisk na akcii 0.33
EPS - Kvartální růst 800.00 %
EPS - Očekávaný růst příští rok -33.33 %
Return on assets 14.11 %
Return on equity 31.75 %
ROIC 15.60 %
ROCE 22.99 %
Dluhy/Equity 1.22
Čistý dluh/EBITDA -4.13
Current ratio 3.07
Quick Ratio 2.78
Volatilita 3.73
Beta 0.92
RSI 56.47
Cílová cena analytiků 8
Známka akcie (dle analytiků) 1.00
Insider ownership 2.57 %
Institutional ownership 72.16 %
Počet akcií 98.598M
Procento shortovaných akcií 4.11 %
Short ratio 5.19 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2002
Země United States

Finanční výsledky akcie BDSI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$111.389$55.64$61.985$15.546$48.231$38.944
Cost Of Goods Sold$21.59$15.783$19.496$11.258$8.101$4.939
Gross Profit$89.799$39.857$42.489$4.288$40.13$34.005
Research And Development Expenses-$4.903$13.04$18.878$20.624$34.285
SG&A Expenses$86.063$58.602$58.869$49.345$54.685$38.46
Other Operating Income Or Expenses------
Operating Expenses$107.653$79.288$91.405$79.481$83.41$77.684
Operating Income$3.736$-23.648$-29.42$-63.935$-35.179$-38.74
Total Non-Operating Income/Expense$-19.036$-10.206$18.733$-3.203$-2.493$-15.478
Pre-Tax Income$-15.3$-33.854$-10.687$-67.138$-37.672$-54.218
Income Taxes$0.005$0.013$-15.972---
Income After Taxes$-15.305$-33.867$5.285$-67.138$-37.672$-54.218
Other Income------
Income From Continuous Operations$-15.305$-33.867$5.285$-67.138$-37.672$-54.218
Income From Discontinued Operations------
Net Income$-15.305$-46.367$5.285$-67.138$-37.672$-54.218
EBITDA$12.563$-17.751$-23.302$-62.527$-33.88$-37.645
EBIT$3.736$-23.648$-29.42$-63.935$-35.179$-38.74
Basic Shares Outstanding836355545248
Shares Outstanding836356545248
Basic EPS$-0.18$-0.73$0.10$-1.25$-0.72$-1.12
EPS - Earnings Per Share$-0.18$-0.73$0.09$-1.25$-0.72$-1.12
# 2020 2019 2018 2017 2016 2015
Current Ratio2.1813.06621.52012.20293.29522.6715
Long-term Debt / Capital0.45640.63460.8432.52190.41160.0637
Debt/Equity Ratio0.83951.73675.3689-1.65710.9110.2151
Gross Margin80.617571.633768.547227.582783.203787.3177
Operating Margin3.354-42.5018-47.4631-411.2634-72.9386-99.4762
EBIT Margin3.354-42.5018-47.4631-411.2634-72.9386-99.4762
EBITDA Margin11.2785-31.9033-37.593-402.2064-70.2453-96.6644
Pre-Tax Profit Margin-13.7357-60.8447-17.2413-431.8667-78.1074-139.2204
Net Profit Margin-13.7401-83.33398.5263-431.8667-78.1074-139.2204
Asset Turnover0.6090.51270.70360.30060.46930.4384
Inventory Turnover Ratio1.90862.91953.20083.34263.16692.7019
Receiveable Turnover2.87164.08317.00245.239619.385512.3986
Days Sales In Receivables127.107389.393552.125269.661318.828629.4388
ROE - Return On Equity-21.9389-113.876959.5493380.0187-118.8616-99.6764
Return On Tangible Equity-228.6717350.0103-14.8048296.2188-146.4412-114.2514
ROA - Return On Assets-8.3677-31.20435.9988-129.8105-36.6559-61.0288
ROI - Return On Investment-11.9261-41.60879.3479-578.4269-69.9391-93.3216
Book Value Per Share0.72540.42020.1588-0.32640.60131.0545
Operating Cash Flow Per Share0.51480.19370.4302-0.93440.52510.9878
Free Cash Flow Per Share0.51560.1920.4377-0.92860.54480.9567